GlassScriptPhysician profile
Alexandra May Vasquez
NPI 1881473379
$573.33
in general payments reported to CMS, 2019-2025
15 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $255 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $85.12 | 2024-2025 | Zepbound, Mounjaro |
| Alexion Pharmaceuticals, INC. | $63.57 | 2025 | Strensiq |
| Glaxosmithkline, LLC. | $53.23 | 2024-2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $51.78 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.24 | 2024 | |
| Conmed Corporation | $47.16 | 2025 | Airseal, Visiclear |
| Radius Health, INC. | $44.63 | 2024-2025 | Tymlos |
| Abbvie INC. | $34.09 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $28.80 | 2025 | |
| Becton, Dickinson and Company | $23.78 | 2025 | Galaflex |
| Abbott Laboratories | $22.59 | 2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.69 | 2024 | Jardiance |
| Mannkind Corporation | $17.46 | 2024 | |
| Pfizer INC. | $16.98 | 2024 | |
| Zoll Respicardia, INC. | $13.21 | 2024 | Remede System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Vasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.